Flagship Harbor Advisors LLC Has $1.64 Million Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Flagship Harbor Advisors LLC grew its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 96.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,192 shares of the exchange traded fund’s stock after purchasing an additional 8,938 shares during the period. Flagship Harbor Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,638,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Avior Wealth Management LLC grew its position in SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after buying an additional 307 shares in the last quarter. Tidemark LLC lifted its position in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares during the period. Quintet Private Bank Europe S.A. bought a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $40,000. ORG Wealth Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at $44,000. Finally, Howe & Rusling Inc. acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at $49,000.

SPDR S&P Biotech ETF Price Performance

XBI opened at $92.46 on Monday. The company has a market capitalization of $7.05 billion, a P/E ratio of 11.47 and a beta of 1.11. The firm’s fifty day moving average price is $93.34 and its two-hundred day moving average price is $96.90. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.